Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy

Clinical trial NCT03631641 · TERMINATED

Trial details

NCT number: NCT03631641
Sponsor: John Hays
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Colon Adenoma Colon Carcinoma Lynch Syndrome MLH1 Gene Mutation MSH2 Gene Mutation

Start date: 2018-10-04
Primary completion: 2021-01-25
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.